<html><head><link rel="stylesheet" type="text/css" href="css.css"></head><h1 id="artitle">Should We Fast-Track a Vaccine for the Coronavirus?<br></h1><p id="artcont">Itâ€™s complicated. By William B. Schultz Mr. Schultz, a partner in a Washington law firm, was the deputy commissioner for policy at the Food and Drug Administration from 1994 to 1999. The Food and Drug Administration is about to make the most momentous decision in its history: whether to authorize the early use of a vaccine to protect against the coronavirus without the normal safety and effectiveness protocols. This is happening against the backdrop of the presidential election season, in which the pandemic has become a fraught political issue for the Trump administration. The wrong decision could seriously undermine efforts to prevent the spread of this deadly virus. 